Financial calendar
An overview of DSM's key financial events for the next 12 months.
Analysts & Vara consensus
Our coverage & latest figures
Sell-side analyst coverage
A wide range of sell-side analysts provide coverage of DSM for their clients and the broader market is contributing to the VARA consensus in 2019/20.
| Institution | Analyst |
|---|---|
| ABN AMRO | Mutlu Gundogan |
| AllianceBernstein | Gunther Zechman |
| Baader Helvea | Laura Lopez Pineda |
| Bank of America Merrill Lynch | Matthew Yates |
| Barclays | Sebastian Satz |
| Berenberg Bank | Sebastian Bray |
| Citigroup | Thomas Wrigglesworth |
| Credit Suisse | Chris Counihan |
| Davy Research | Katy Hutchinson |
| Deutsche Bank | Virginie Boucher-Ferte |
| Equita | Massimo Bonisoli |
| Exane BNP Paribas | Nicola Tang |
| Goldman Sachs | Theodora Lee Joseph |
| HSBC | Martin Evans |
| ING | Reg Watson |
| Jefferies | Laurence Alexander |
| JP Morgan | Chetan Udeshi |
| KBC Securities | Wim Hoste |
| Kepler Chevreux | Martin R?diger |
| Mainfirst Bank | Andreas Heine |
| Morgan Stanley | Alexandra Thrum |
| DeGroof Petercam | Fernand de Boer |
| Redburn | Ranulf Orr |
| Société Générale | Thomas Swoboda |
| The Idea | Paul Hofman |
| UBS | Andrew Stott |
Disclaimer
Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. By providing the names of the analysts, DSM does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. DSM assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.
Latest consensus figures
The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.
Analysts’ consensus Q1 2020 and FY 2020 as at 8 April 2020
| ? | Q1 2019 | FY 2019 | Q1 2020 (est.) | FY?2020 (est.) |
|---|---|---|---|---|
| Sales (continuing) | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 23 |
| Highest | ? | ? | 2,341 | 9,462 |
| Consensus | 2,292 | 9,010 | 2,241 | 8,961 |
| Median | ? | ? | 2,238 | 8,940 |
| Lowest | ? | ? | 2,164 | 8,443 |
| adjusted EBITDA (continuing) | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 23 |
| Highest | ? | ? | 425 | 1,825 |
| Consensus | 424 | 1,684 | 412 | 1,675 |
| Median | ? | ? | 416 | 1,682 |
| Lowest | ? | ? | 373 | 1,520 |
| adjusted EBIT (continuing) | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 22 |
| Highest | ? | ? | 276 | 1,209 |
| Consensus | 279 | 1,075 | 256 | 1,061 |
| Median | ? | ? | 259 | 1,054 |
| Lowest | ? | ? | 208 | 897 |
| ? | ? | ? | ? | ? |
| Nutrition, Sales | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 22 |
| Highest | ? | ? | 1,617 | 6,577 |
| Consensus | 1,517 | 6,028 | 1,543 | 6,292 |
| Median | ? | ? | 1,537 | 6,282 |
| Lowest | ? | ? | 1,480 | 6,004 |
| Nutrition, adjusted EBITDA | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 21 |
| Highest | ? | ? | 331 | 1,425 |
| Consensus | 316 | 1,250 | 319 | 1,320 |
| Median | ? | ? | 321 | 1,337 |
| Lowest | ? | ? | 294 | 1,198 |
| Nutrition, adjusted EBIT | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 20 |
| Highest | ? | ? | 238 | 1,050 |
| Consensus | 228 | 881 | 222 | 939 |
| Median | ? | ? | 223 | 959 |
| Lowest | ? | ? | 194 | 810 |
| Materials, Sales | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 22 |
| Highest | ? | ? | 697 | 2,644 |
| Consensus | 717 | 2,746 | 638 | 2,435 |
| Median | ? | ? | 640 | 2,464 |
| Lowest | ? | ? | 592 | 1,906 |
| Materials, adjusted EBITDA | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 21 |
| Highest | ? | ? | 121 | 481 |
| Consensus | 127 | 509 | 112 | 437 |
| Median | ? | ? | 112 | 443 |
| Lowest | ? | ? | 98 | 338 |
| Materials, adjusted EBIT | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 20 |
| Highest | ? | ? | 86 | 351 |
| Consensus | 93 | 363 | 76 | 295 |
| Median | ? | ? | 76 | 300 |
| Lowest | ? | ? | 58 | 178 |
| Innovation Center, Sales | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 22 |
| Highest | ? | ? | 56 | 235 |
| Consensus | 47 | 194 | 49 | 202 |
| Median | ? | ? | 49 | 202 |
| Lowest | ? | ? | 45 | 180 |
| Innovation Center, adjusted EBITDA | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 21 |
| Highest | ? | ? | 9 | 37 |
| Consensus | 6 | 22 | 6 | 26 |
| Median | ? | ? | 6 | 26 |
| Lowest | ? | ? | 5 | 20 |
| Innovation Center, adjusted EBIT | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 20 |
| Highest | ? | ? | -1 | -5 |
| Consensus | -1 | -19 | -4 | -16 |
| Median | ? | ? | -4 | -16 |
| Lowest | ? | ? | -8 | -32 |
| Corporate Activities, Sales | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 21 | 22 |
| Highest | ? | ? | 18 | 70 |
| Consensus | 11 | 42 | 11 | 45 |
| Median | ? | ? | 11 | 44 |
| Lowest | ? | ? | 10 | 39 |
| Corporate Activities, adjusted EBITDA | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 21 |
| Highest | ? | ? | -21 | -82 |
| Consensus | -25 | -97 | -25 | -99 |
| Median | ? | ? | -25 | -99 |
| Lowest | ? | ? | -32 | -118 |
| Corporate Activities, adjusted EBIT | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 20 | 20 |
| Highest | ? | ? | -34 | -136 |
| Consensus | -41 | -150 | -38 | -150 |
| Median | ? | ? | -38 | -150 |
| Lowest | ? | ? | -43 | -162 |
| Profit for the period, before exceptional items - Continuing Operations | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 19 | 22 |
| Highest | ? | ? | 208 | 872 |
| Consensus | 200.0 | 830.0 | 184 | 778 |
| Median | ? | ? | 186 | 779 |
| Lowest | ? | ? | 137 | 606 |
| Net EPS before exceptional items - Continuing Operations | ? | ? | ? | ? |
| Number of Estimates | ? | ? | 19 | 22 |
| Highest | ? | ? | 1.23 | 5.26 |
| Consensus | 1.12 | 4.64 | 1.06 | 4.53 |
| Median | ? | ? | 1.08 | 4.47 |
| Lowest | ? | ? | 0.77 | 3.44 |
Disclaimer
Consensus earnings estimates are based on earnings projections made by securities analysts who cover DSM. Any opinions, forecasts, estimates, projections or predictions regarding DSM’s performance made by the analysts (and, therefore, the Consensus estimate numbers) are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of DSM or its management. DSM does not by providing these estimates imply its endorsement of or concurrence with such information, conclusions or recommendations. DSM assumes no liability for the accuracy of such estimates and undertakes no obligation to update or revise such estimate
Read more
-
-
Results center
Instant overview of the financial results, updates, presentations & AGMs and all DSM's financial and regulatory press releases from the last decade.
-
Share center
DSM's ordinary shares, share performance, share listings, share structure, cumulative preference shares and shareholder base.